Abstract 5551: SGN-2FF: A small-molecule inhibitor of fucosylation modulates immune cell activity in preclinical models and demonstrates pharmacodynamic activity in early phase 1 analysis


Conference Paper

Full Text

Duke Authors

Cited Authors

  • Okeley, NM; Heiser, RA; Zeng, W; Hengel, SM; Wall, J; Haughney, PC; Yap, TA; Robert, F; Sanborn, RE; Burris, H; Chow, LQ; Do, KT; Gutierrez, M; Reckamp, K; Weise, A; Camidge, DR; Strickler, J; Steuer, C; Wang, Z; O'Meara, MM; Alley, SC; Gardai, SJ

Published Date

  • July 1, 2018

Published In

  • Clinical Research (Excluding Clinical Trials)

Published By

Digital Object Identifier (DOI)

  • 10.1158/1538-7445.am2018-5551

Conference Name

  • Proceedings: AACR Annual Meeting 2018; April 14-18, 2018; Chicago, IL